CD163 and neoplasm: Sun et al. summarized that the upregulated lncRNA XIST promoted macrophage conversion to M2 characterized by the deletion of specific makers like IL-10 and CD163, to affect tumor invasion and migration of lung cancer (Sun and Xu, 2019).